Bromazolam is a triazolobenzodiazepine which was first synthesised in 1976, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified by the EMCDDA in Sweden in 2016. From Wikipedia
Attorneys general from 21 states are urging emergency federal scheduling to close a gap that leaves bromazolam unscheduled nationwide.
